Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
A federal judge in New York dismissed a lawsuit against Curaleaf from investors who argued
Continue Reading CBD and Hemp Legal and Regulatory Roundup – February 19, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
Not only are retailers, like Sephora, Vitamin Shopped, CVS, and Walgreen’s stocking shelves with CBD
Continue Reading CBD and Hemp Legal and Regulatory Roundup – February 12, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
While many states have legalized medical and recreational marijuana, marijuana remains an illegal controlled substance under federal law. As we
Continue Reading CBD and Hemp Legal and Regulatory Roundup
As 2020 drew to a close and Congress scrambled to reach a deal to continue funding the federal government, tucked in amidst the 2124 pages of the 2021 Appropriations Bill is a new power for the FTC: civil penalty authority
Continue Reading ICYMI: The FTC Has Civil Penalty Authority Relative To COVID-Related Advertising
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
The removal of an FDA review of a CBD enforcement policy was anticipated as the
Continue Reading CBD and Hemp Legal and Regulatory Roundup
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
USPS reminds carriers about mail restrictions for CBD products
Products made with CBD oil have become popular, but there are restrictions when it comes to mailing
Continue Reading CBD and Hemp Legal and Regulatory Roundup
The FTC announced yesterday settlements with six companies accused of making a broad range of unsubstantiated health claims, including that CBD can treat cancer, heart disease, hypertension, Alzheimer’s disease, bipolar disorder, and chronic pain, among others. Nicknamed, “Operation CBDeceit,” the
Continue Reading FTC’s CBD Crackdown: Something Old and Something New
On May 22, Central California District Court Judge Virginia A. Phillips granted CBD retailer CV Sciences, Inc.’s (CV Sciences) request to stay the case of Colette et al. v. CV Sciences Inc., Case No. 2:19-cv-10227 (C.D. Cal), until the
Continue Reading Another Federal Court Halts False Advertising Case Pending FDA Review of CBD
Earlier this week, federal regulators continued their efforts to combat the spread of products featuring allegedly false and misleading claims that products can diagnose, treat, cure, or prevent COVID-19. In warning letters issued to CBD Gaze, Alternavita, Musthavemom.com
Continue Reading FDA and FTC Joint Warning Letters Target Amazon Affiliates Making False COVID-19 Claims
On April 29, the National Advertising Division (“NAD”) recommended that Talyoni Professional, LLC and its affiliate, Ecoco, Inc. (collectively “Talyoni”) discontinue express claims that the companies’ cosmetic and wellness products contain CBD, as well as product performance claims based on
Continue Reading The Proof Is In The Product: National Advertising Division (NAD) Recommends CBD Company Discontinue Claims
In a somewhat mixed decision for cannabis company defendants, a false advertising class action lawsuit will proceed in the Southern District of Florida – and not be halted while waiting for guidance from the FDA – although some of the
Continue Reading Florida Court Permits CBD Mislabeling Case to Proceed
